The Doris Duke Charitable Foundation (DDCF) has announced that Daniel S. Herman, MD, PhD, Assistant Professor of Pathology and Laboratory Medicine, is one of the sixteen recipients of the 2019 Doris Duke Charitable Foundation Clinical Scientist Development Award (CSDA). The award aims to strengthen the clinical research field by providing opportunities that help advance the careers of young scientists and provides funding for physician-scientists as they transition to independent research careers.

The three-year award for $495,000 will support Dr. Herman's current work on the development and implementation of statistical methods and informatics tools that leverage clinical data for decision support to improve screening for primary aldosteronism. Dr. Herman’s computational medicine lab focuses on developing and applying methods to improve clinical care for cryptic, under-diagnosed diseases, as well as cardiovascular disease diagnosis and prediction. Approaches that can be rapidly implemented in clinical practice and more sophisticated modeling that optimally leverages longitudinal, multi-dimensional patient data are also studied. Dr. Herman is the Director of the Endocrine Laboratory in the Division of Laboratory Medicine, which performs assays to measure various hormones, tumor markers, and infectious disease serologic markers.

Dr. Herman holds an MD and a PhD from Harvard Medical School and completed his Clinical Pathology residency at the University of Washington. He was the recipient of the Young Investigator Award from the American Association of Clinical Chemistry, Philadelphia Section, in 2018 and from the Academy of Clinical Laboratory Physicians and Scientists (ACLPS) in 2016.   

Since 1998, the DDCF has awarded 304 Clinical Scientist Development Awards. The Foundation’s Medical Research Program supports clinical research that advances the translation of biomedical discoveries into new preventions, diagnoses and treatments for human diseases.

Read more in the DDCF press release.